First Time Loading...

Reata Pharmaceuticals Inc
NASDAQ:RETA

Watchlist Manager
Reata Pharmaceuticals Inc Logo
Reata Pharmaceuticals Inc
NASDAQ:RETA
Watchlist
Price: 172.36 USD
Updated: May 15, 2024

Reata Pharmaceuticals Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Reata Pharmaceuticals Inc
Interest Income Expense Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Reata Pharmaceuticals Inc
NASDAQ:RETA
Interest Income Expense
$11.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Interest Income Expense
$212m
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Interest Income Expense
-$676m
CAGR 3-Years
N/A
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Interest Income Expense
$1.5B
CAGR 3-Years
130%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Interest Income Expense
-$1.2B
CAGR 3-Years
N/A
CAGR 5-Years
-30%
CAGR 10-Years
-13%
Eli Lilly and Co
NYSE:LLY
Interest Income Expense
-$368m
CAGR 3-Years
-133%
CAGR 5-Years
-10%
CAGR 10-Years
-30%

See Also

What is Reata Pharmaceuticals Inc's Interest Income Expense?
Interest Income Expense
11.2m USD

Based on the financial report for Jun 30, 2023, Reata Pharmaceuticals Inc's Interest Income Expense amounts to 11.2m USD.